ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,854Medicare Part D Prescriptions Filled, Including Refills

Rank: 85 out of 1290

$380K Total Retail Price of All Prescriptions

Rank: 276 out of 1290

313 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 313 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

16% of this provider’s 313 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 7,026 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 375 327 1 1
AMLODIPINE BESYLATE 368 318 2 3
LISINOPRIL 338 288 3 5
LEVOTHYROXINE SODIUM 322 257 4 4
METOPROLOL TARTRATE 309 233 5 7
FUROSEMIDE 235 201 6 9
GABAPENTIN 217 165 7 8
OMEPRAZOLE 181 129 8 2
GLIPIZIDE 174 136 9 81
WARFARIN SODIUM 172 151 10 22
TRAMADOL HCL 172 133 10 25
CLONIDINE HCL 163 142 12 66
POTASSIUM CHLORIDE 141 128 13 35
HYDROCHLOROTHIAZIDE 132 93 14 20
METFORMIN HCL 131 93 15 10
RAMIPRIL 125 115 16 136
NAPROXEN 122 97 17 115
SERTRALINE HCL 122 118 17 36
AZITHROMYCIN 115 85 19 61
MELOXICAM 110 78 20 31
TAMSULOSIN HCL 110 88 20 11
HYDROCODONE-ACETAMINOPHEN 106 89 S3 22 6
METOPROLOL SUCCINATE 102 89 23 14
LEVETIRACETAM 94 58 24 70
ALENDRONATE SODIUM 94 66 24 39
CITALOPRAM HBR 90 58 26 29
CLOPIDOGREL 88 73 27 24
IBUPROFEN 87 57 28 74
LOVASTATIN 79 54 29 45
ATENOLOL 77 69 30 18
NAMENDA 76 76 31 27
ATORVASTATIN CALCIUM 74 68 32 23
CARVEDILOL 68 61 33 12
ESCITALOPRAM OXALATE 68 64 33 63
METHYLPREDNISOLONE 66 53 35 101
LANTUS 64 46 36 67
MIRTAZAPINE 58 54 37 93
DONEPEZIL HCL 57 57 38 13
LOSARTAN POTASSIUM 57 54 38 19
NOVOLOG 56 45 40 167
PLAVIX 53 45 41 32
HYDRALAZINE HCL 53 50 41 133
RISPERIDONE 53 23 41 68
NIASPAN 50 19 44 210
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 6, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.